These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6888192)

  • 1. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors.
    Owen F; Poulter M; Mashal RD; Crow TJ; Veall N; Zanelli GD
    Life Sci; 1983 Aug; 33(8):765-8. PubMed ID: 6888192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone.
    Mazière B; Loc'h C; Baron JC; Sgouropoulos P; Duquesnoy N; D'Antona R; Cambon H
    Eur J Pharmacol; 1985 Aug; 114(3):267-72. PubMed ID: 3877639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors.
    Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M
    Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR; Nahorski SR
    FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine receptors displayed in living human brain with 77Br-p-bromospiperone.
    Crawley JC; Smith T; Veall N; Zanelli GD; Crow TJ; Owen F
    Lancet; 1983 Oct; 2(8356):975. PubMed ID: 6138540
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of lipophilicity on the in vivo localization of radiolabelled spiperone analogues.
    Moerlein SM; Laufer P; Stöcklin G
    Int J Nucl Med Biol; 1985; 12(5):353-6. PubMed ID: 3833821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
    Bischoff S
    Experientia; 1981; 37(9):1008-9. PubMed ID: 7297644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG; Sinha YN; Finch CE
    Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific in vivo binding of 77Br-brombenperidol in rat brain.
    Moerlein SM; Stöcklin G
    Life Sci; 1984 Sep; 35(13):1357-63. PubMed ID: 6482657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phospholipids on the specific binding of [3H]spiroperidol to the cholate extract of rat brain synaptic membranes.
    Moroi K; Hsu LL
    Int J Biochem; 1985; 17(5):637-44. PubMed ID: 4029482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
    Cross AJ; Waddington JL
    Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN
    Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Paulose CS; Mishra RK
    Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.